Temozolomide and cisplatin in relapsed/refractory acute leukemia. - Wikidata - wikimedia - TriplyDB

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

http://www.wikidata.org/entity/Q37223615

about

Metabolic interrogation as a tool to optimize chemotherapeutic regimens.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.Effects of metal salophene and saldach complexes on lymphoma and leukemia cells.Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer.Functional network analysis of gene-phenotype connectivity associated with temozolomide.Metabolism of cisplatin in the organs of Rattus norvegicus: role of Glutathione S-transferase P1.

P2860

Q33566853-5EB95760-3C71-48A3-A684-0021F31A4CE0 Q38730989-07DAAEDE-4730-4600-8143-3A47249D68ED Q39171305-7325C942-1767-4112-8419-783DD3426872 Q39563449-5FE0E2B2-01CF-494D-9162-23EBEED667ED Q40259652-385370F7-D664-4F5F-A3EE-C02A23CEFB91 Q47258480-73DFF029-C9D5-474F-B97A-7A8CFBDB5D8C Q53298155-ED002A43-8777-443F-AEB4-026264DBAEE4

P2860

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

http://www.wikidata.org/entity/Q37223615

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@en

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@nl

type

label

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@en

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@nl

prefLabel

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@en

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@nl

P1433

Q37223615-F20F8268-3549-4A11-B0AA-05329080ABEF

P1476

Q37223615-B0A52FA4-D77F-4722-B4F8-4BE8F3A64D5A

P2093

Q37223615-1F6F7B3E-1D87-4AF4-98A0-7AE49822280B

Q37223615-2676B530-1280-445B-AAB8-D716764E1D50

Q37223615-976C581C-F696-4DD7-8BA0-BAF16017B343

Q37223615-BE3B22AC-92E2-4D10-8B88-98F7FCF761D0

Q37223615-C87E2ED4-F5FC-47CC-986B-6B80AF375ABD

P2860

Q37223615-1C590976-C245-454C-89AC-46D7531ADFF2

Q37223615-1EFA806E-4911-41B5-BFCC-D07F46E6BE61

Q37223615-249437D3-9D9E-4BD9-A6BE-268EE29AE770

Q37223615-2B697BD4-8BD0-4D5F-A664-95342F9EBE2A

Q37223615-2ED62B31-CC9C-4CE5-B8CD-8BA276439690

Q37223615-2F4630F6-3403-4A5D-B22A-C4E587203E4B

Q37223615-376A7989-66CB-443F-8095-13311A867297

Q37223615-51E36933-0CE2-4F92-8BC9-9C8D7497484D

Q37223615-627D4EFF-8FED-4D3E-848D-53953F7FB328

Q37223615-670CBC79-9583-4B44-9024-5896BDF5EDED

P2888

Q37223615-893AF091-F74A-42F6-862A-D305D4C94DFE

P304

Q37223615-E5092927-BD2E-4531-99F7-39C84B9621CE

P31

Q37223615-0E00179E-5038-43AC-BBA0-1567317024D1

P356

Q37223615-DDC907A3-90A0-40C5-97D0-A26F07F099D6

P478

Q37223615-408CCCEB-3DBC-4047-819D-F21BCA940218

P577

Q37223615-1C38FF4B-315C-4B7C-BC61-CADE17BEC434

P5875

Q37223615-CC577808-91A9-404D-8B96-75771BBB313B

P6179

Q37223615-4C8EB4D4-B138-42C7-906A-23F9972C6B07

P698

Q37223615-69E152D0-3631-4395-A31E-EE7EE419A3B3

P921

Q37223615-123541CB-3AAB-42CE-BCB1-419A14B10328

P932

Q37223615-4C9DBE55-A0A6-44B0-BA16-4C4FCF55C163

P356

P1433

Journal of Hematology & Oncology

P1476

Temozolomide and cisplatin in relapsed/refractory acute leukemia.

@en

P2093

Doris Ponce

http://www.w3.org/2001/XMLSchema#string

Karen Seiter

http://www.w3.org/2001/XMLSchema#string

Muhammad Rasul

http://www.w3.org/2001/XMLSchema#string

Nasir Ahmed

http://www.w3.org/2001/XMLSchema#string

Sreedhar Katragadda

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Treatment of relapsed and refractory acute myelogenous leukemia.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

Outcome of patients with acute myelogenous leukemia after second salvage therapy.

Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells.

Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents.

Influence of O6-methylguanine on DNA damage and cytotoxicity of temozolomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureas.

In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.

Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.

Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.

P2888

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8722-2-21

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26234843

http://www.w3.org/2001/XMLSchema#string

P6179

1034487009

http://www.w3.org/2001/XMLSchema#string

P698

19463179

http://www.w3.org/2001/XMLSchema#string

P921

P932

2694825

http://www.w3.org/2001/XMLSchema#string